| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-11 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-05 |